These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25031446)

  • 41. Comparison of eight commercial enzyme immunoassays for the detection of Clostridium difficile from stool samples and effect of strain type.
    René P; Frenette CP; Schiller I; Dendukuri N; Brassard P; Fenn S; Loo VG
    Diagn Microbiol Infect Dis; 2012 May; 73(1):94-6. PubMed ID: 22424900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Laboratory diagnosis of Clostridium difficile infection: Comparison of Techlab C. diff Quik Chek Complete, Xpert C. difficile, and multistep algorithmic approach.
    Seo JY; Jeong JH; Kim KH; Ahn JY; Park PW; Seo YH
    J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28177534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does the handling time of unrefrigerated human fecal specimens impact the detection of Clostridium difficile toxins in a hospital setting?
    Modi C; DePasquale JR; Nguyen NQ; Malinowski JE; Perez G
    Indian J Gastroenterol; 2010 Jul; 29(4):157-61. PubMed ID: 20740339
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile.
    Pawlowski SW; Archbald-Pannone L; Carman RJ; Alcantara-Warren C; Lyerly D; Genheimer CW; Gerding DN; Guerrant RL
    J Hosp Infect; 2009 Oct; 73(2):185-7. PubMed ID: 19709778
    [No Abstract]   [Full Text] [Related]  

  • 45. Superiority of the DNA amplification assay for the diagnosis of C. difficile infection: a clinical comparison of fecal tests.
    Barkin JA; Nandi N; Miller N; Grace A; Barkin JS; Sussman DA
    Dig Dis Sci; 2012 Oct; 57(10):2592-9. PubMed ID: 22576711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease.
    Wultańska D; Banaszkiewicz A; Radzikowski A; Obuch-Woszczatyński P; Młynarczyk G; Brazier JS; Pituch H; van Belkum A
    Eur J Clin Microbiol Infect Dis; 2010 Oct; 29(10):1265-70. PubMed ID: 20577773
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Environmental shedding of toxigenic Clostridioides difficile by asymptomatic carriers: A prospective observational study.
    Gilboa M; Houri-Levi E; Cohen C; Tal I; Rubin C; Feld-Simon O; Brom A; Eden-Friedman Y; Segal S; Rahav G; Regev-Yochay G;
    Clin Microbiol Infect; 2020 Aug; 26(8):1052-1057. PubMed ID: 31904567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Are Clostridioides difficile infections being overdiagnosed in hematopoietic stem cell transplant recipients?
    Ford CD; Lopansri BK; Coombs J; Webb BJ; Asch J; Hoda D
    Transpl Infect Dis; 2020 Aug; 22(4):e13279. PubMed ID: 32196881
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Direct Clostridioides difficile ribotyping from stool using capillary electrophoresis.
    Lloyd CD; Shah-Gandhi B; Parsons BD; Morin SBN; Du T; Golding GR; Chui L
    Diagn Microbiol Infect Dis; 2021 Mar; 99(3):115259. PubMed ID: 33217718
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.
    Tenover FC; Novak-Weekley S; Woods CW; Peterson LR; Davis T; Schreckenberger P; Fang FC; Dascal A; Gerding DN; Nomura JH; Goering RV; Akerlund T; Weissfeld AS; Baron EJ; Wong E; Marlowe EM; Whitmore J; Persing DH
    J Clin Microbiol; 2010 Oct; 48(10):3719-24. PubMed ID: 20702676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multicenter evaluation of the Verigene Clostridium difficile nucleic acid assay.
    Carroll KC; Buchan BW; Tan S; Stamper PD; Riebe KM; Pancholi P; Kelly C; Rao A; Fader R; Cavagnolo R; Watson W; Goering RV; Trevino EA; Weissfeld AS; Ledeboer NA
    J Clin Microbiol; 2013 Dec; 51(12):4120-5. PubMed ID: 24088862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ultrasensitive Detection of Clostridioides difficile Toxins A and B by Use of Automated Single-Molecule Counting Technology.
    Sandlund J; Bartolome A; Almazan A; Tam S; Biscocho S; Abusali S; Bishop JJ; Nolan N; Estis J; Todd J; Young S; Senchyna F; Banaei N
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30158195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation between Clostridium difficile bacterial load, commercial real-time PCR cycle thresholds, and results of diagnostic tests based on enzyme immunoassay and cell culture cytotoxicity assay.
    Dionne LL; Raymond F; Corbeil J; Longtin J; Gervais P; Longtin Y
    J Clin Microbiol; 2013 Nov; 51(11):3624-30. PubMed ID: 23966497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The correlation between Clostridium-difficile infection and human gut concentrations of Bacteroidetes phylum and clostridial species.
    Goldberg E; Amir I; Zafran M; Gophna U; Samra Z; Pitlik S; Bishara J
    Eur J Clin Microbiol Infect Dis; 2014 Mar; 33(3):377-83. PubMed ID: 24048726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and microbiologic characteristics of tcdA-negative variant Clostridium difficile infections.
    Kim J; Pai H; Seo MR; Kang JO
    BMC Infect Dis; 2012 May; 12():109. PubMed ID: 22571633
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical features of Clostridium difficile infection and molecular characterization of the isolated strains in a cohort of Danish hospitalized patients.
    Søes LM; Brock I; Persson S; Simonsen J; Pribil Olsen KE; Kemp M
    Eur J Clin Microbiol Infect Dis; 2012 Feb; 31(2):185-92. PubMed ID: 21744281
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay Results.
    Kwon JH; Reske KA; Hink T; Burnham CA; Dubberke ER
    J Clin Microbiol; 2017 Feb; 55(2):596-605. PubMed ID: 27927930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multicenter evaluation of the Quidel Lyra Direct C. difficile nucleic acid amplification assay.
    Beck ET; Buchan BW; Riebe KM; Alkins BR; Pancholi P; Granato PA; Ledeboer NA
    J Clin Microbiol; 2014 Jun; 52(6):1998-2002. PubMed ID: 24671790
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The interplay of SARS-CoV-2 and
    Khanna S; Kraft CS
    Future Microbiol; 2021 Apr; 16():439-443. PubMed ID: 33847139
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing?
    Leslie JL; Cohen SH; Solnick JV; Polage CR
    Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3295-9. PubMed ID: 22814877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.